Revolution Share Price

Revolution Share Price

NASDAQ: RVMDW | Small Cap | Healthcare
$6.49
-$0.11 (-1.67%) Last updated on 20 Nov, 2026 | 23:34 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Revolution Stock Performance

Open
N/A
Prev. Close
$6.60
Circuit Range
N/A
Day Range
N/A
Year Range
$0.55 - $12.32
Volume
N/A
Average Traded
N/A

Revolution Share Price Chart

Line chart of the Revolution price trend over the selected period. The price fell overall, ranging from 6.49 to 6.49, ending at 6.49.
$0.00$0.00
L
Show Current Price
H

Revolution Stock Fundamentals & Key Indicators

Market Cap
$1.23B
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
-77.89%
Profit Margin
N/A
Debt to Equity
0.20
Quarterly Earnings Growth YoY
-11.67%

Revolution Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$197.56
Net Profit-$364.89-$453.82-$644.37-$407.46
Net Profit MarginN/AN/AN/A-206.25%
Income ChangeN/A-24.37%-41.99%36.77%

Revolution Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$11.58$0.00$0.00
Net Profit-$436.37-$600.09-$1131.30
Net Profit Margin-3768.31%N/AN/A
Income ChangeN/A-37.52%-88.52%

Revolution Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets279.47230.67182.42
Current Assets2075.042327.631879.28
Total Assets2354.512558.32061.71
Non Current Liabilities432.79129.1891.66
Current Liabilities290.42163.91143.85
Total Liabilities723.21293.1235.51
Shareholders' Equity1631.32265.21826.19

Revolution Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-897.74-557.44-350.57
Investing118.06-554.39-342.6
Financing621.52959.411,229.2

About Revolution

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Revolution Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$10.20
$6.49
-31.14%
Oct 2026
$8.65
$9.43
-22.36%
Aug 2026
$8.96
$12.14
+26.06%
Jul 2026
$9.24
$9.63
-3.22%
Jun 2026
$6.23
$9.95
+62.05%
May 2026
$4.72
$6.14
+23.79%
Apr 2026
$1.96
$4.96
+191.76%
Mar 2026
$1.92
$1.70
-21.30%
Feb 2026
$1.41
$2.16
+41.18%
Jan 2026
$0.78
$1.53
+61.05%
Dec 2025
$0.80
$0.95
+137.50%
Nov 2025
$0.40
$0.40
+0.50%

Revolution Share Price FAQs